Following a request by Congress to evaluate the effects of changes in how Medicare pays for drugs administered by oncologists, the Medicare Payment Advisory Commission (MedPAC) issued three recommendations in its recently released report. Practice Manager Insider will publish a series of posts about the report’s findings, along with comments and analysis from our distinguished editorial board of experts in the business of oncology. We look forward to reading your comments.
Recent Comments